Home / MidAtlantic Urology Associates Clinical Research
We have over 30 years of experience doing urologic research and have participated in over 250 clinical research trials. We have conducted trials in urology as well as many other areas in medicine. Our dedicated research team has of 3 full time staff.
Highlights of Past Clinical Trials
Participated in research on Provenge, the first vaccine treatment for metastatic prostate cancer approved by FDA in May 2010. We are an approved urology treatment center currently infusing qualified patients with Provenge.
Participated in research on localized and metastatic prostate cancer.
Participated in research on bladder cancer.
Participated in initial research on Viagra, Cialis, and Levitra
Participated in research on all overactive bladder medications, including Vesicare, Enablex, Toviaz, Santura XR, Detrol LA,and Ditropan.
Participated in research on all prostate enlargement drugs, including Flomax, Rapaflo, Uroxatral, Avodart and Proscar.
Participated in research on diabetes.
Participated in research on low testosterone treatments, including Androgel, Testim, and Depo-Testosterone.
Participated in research on liver function and chronic viral hepatitis.
Current Enrolling Clinical Trials
Contact our research department at 301-477-2000 to see if you are eligible to participate in one of our enrolling studies on:
Nocturia Study:Click Hereto learn more (.pdf file)